Expert NetworkExpert InterviewMDGL

Slingshot members are talking to an expert! The topic is:

Exploring the current treatment landscape and the future direction of available NASH specific drugs with the introduction of GLP-1 agonists

Executed on:Sep 19, 2023 10:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Virginia Commonwealth University School of Medicine
  • Director of Alcohol Sciences at Stravitz-Sanyal Institute for Liver Disease and Associate Professor of Medicine in Gastroenterology, Hepatology, and Nutrition, at  Virginia Commonwealth University School of Medicine
  • Treats 1000 patients per year with MASH
  • Research interest in clinical/translational research and epidemiology in alcohol-related liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD).

Interview Goal

This interview will focus on understanding the roles GLP-1 agonists play in the NASH treatment landscape and the future direction of specific NASH drugs. 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.